About this trial
Due to increasing of life expectancy, patients with von Willebrand disease are exposed to age-related pathologies such as cancer or cardiovascular diseases. Management of thrombotic events is challenging given the inherent bleeding risk in von Willebrand disease. Few data are currently available in the literature.
The aim of the study is to describe the frequency and nature of arterial and venous thromboembolic events and atrial fibrillation in patients with von Willebrand disease in the West of France.
The investigators will perform a retrospective multicenter study conducted in the von Willebrand population of the French West. Von Willebrand adult patients followed in one of the French West medical centers participating in the study, who presented deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia, atrial fibrillation, arteriopathy of the lower limbs, angina will be eligible.
Eligibility criteria
Qualifiers
Von Willebrand disease
Adult
Followed-up in a reference center of West of France (Caen, Brest, Nantes, Rennes, Le Mans, Angers)
Consented to be included in BERHLINGO database
Disqualifiers
- Expression of opposition
Acquired von Willebrand syndrome
Patients under legal protection
Minor
Trial design
Treatments tested in this trial
- Not listed